Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine in Cystectomy
NCT02924480Completed
- Sponsor
- CAMC Health System
- Start
- Oct 2016
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative pain and postoperative ileus (POI) comparing Lidocaine Study Group with Placebo Study Group (2 arms). Primary endpoints: Reduced pain post-operatively using verbal analog score at 108 hours and Time until Ileus resolution at 108 hours. Started Oct 2016; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT02924480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02924480.